Brain Tumor Treatments: Ohio
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details

[Click HERE to print this page!]
Braintumor Website

Search Term: Ohio
Please scroll down to see the matching trials.

  (0.8169)   Brain Tumor Treatments: Ohio
  (0.8169)   Virtualtrials Newsletter
  (0.7967)   RSR-13
  (0.7967)   RSR-13
  (0.7967)   RSR-13
  (0.7742)   Untitled Document
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism
  (0.7742)   Brain tumor News
  (0.7742)   Changes to the website

Sorry - There were no pages found that contain that search phrase.



  Treatment Location Last Updated
Details A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Cleveland, OH USA 07/03/2008
Details A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Cleveland, OH USA 07/03/2008
Details A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Columbus, OH USA 07/03/2008
Details A Phase II trial of RAD001 in patients with recurrent glioblastoma multiforme (Study # CRAD001C2410 Cincinnati, Oh USA 06/04/2008
Details Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer Cincinnati, Oh USA 06/04/2008
Details Phase I Study of Multi-modality Treatment for Patients with Newly Diagnosed Glioblastoma Multiforme Using Concurrent Gliadel Wafers and Permanent I-125 Seeds Cincinnati, Oh USA 06/04/2008
Details A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Back up Stereotactic Radiation Therapy Cincinnati, Oh USA 06/04/2008
Details Effect of NovoTTF-100A in Recurrent GBM Cleveland, OH USA 05/28/2008
Details Effect of NovoTTF-100A in Recurrent GBM Cleveland, OH USA 05/28/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Akron, OH USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Akron, OH USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Canton, OH USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Wooster, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Akron, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Cleveland, OH 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma , OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Akron, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Chillicothe, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Akron, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Canton, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Wooster, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Columbus, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Zanesville, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Columbus, OH USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Columbus, OH USA 04/11/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Columbus, OH USA 03/01/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Columbus, OH USA 03/01/2008
Details A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas Cincinnati,, OH USA 08/26/2007
Details A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas Columbus, OH USA 08/26/2007
Details A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme Cleveland, OH USA 08/26/2007
Details A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme Cleveland, OH USA 08/19/2007
Details Identification of factors associated with brain metastasis in women with breast cancer: development of a predictive nomogram Cleveland, OH USA 08/18/2007
Details Identification of Hypermethylated Serum Tumor DNA in High Grade Glioma Patients and Correlation with Magnetic Resonance Imaging Findings Cleveland, OH USA 08/18/2007
Details Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor Columbus, OH USA 08/18/2007
Details Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers Cleveland, OH USA 05/01/2007
Details Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma Cleveland, OH USA 05/01/2007
Details Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma Cleveland, OH USA 05/01/2007
Details Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma Cleveland, OH USA 05/01/2007
Details Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer Cleveland, OH USA 05/01/2007
Details Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma Cleveland, OH USA 05/01/2007
Details A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection Cincinnati , OH USA 05/01/2007
Details Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma Columbus, OH USA 05/01/2007
Details Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma Cleveland, OH USA 05/01/2007
Details Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas Cleveland, OH USA 05/01/2007
Details Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Cleveland, OH USA 05/01/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Cleveland, OH 05/01/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas , OH USA 05/01/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Akron, OH USA 05/01/2007
Details A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis Cleveland, OH USA 05/01/2007
Details Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Cleveland, OH 05/01/2007
Details Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Akron, OH USA 05/01/2007
Details Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma Cleveland, OH USA 05/01/2007
Details Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases Cleveland, OH USA 05/01/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas Cleveland, OH USA 04/29/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas Dayton, OH USA 04/29/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas Cleveland, OH USA 04/29/2007
Details A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma Cleveland, OH USA 04/28/2007
Details Boswellia Serrata Combined With a Low-Fat, Vegan Diet or a Standard Diet Alone in Treating Patients Who Have Undergone Surgery and Radiation Therapy for Newly Diagnosed Glioblastoma Multiforme Cleveland, OH USA 04/28/2007
Details Phase II Study of Erlotinib in Patients With Recurrent or Progressive Glioblastoma Multiforme Cleveland, OH USA 04/15/2007
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Akron, OH USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Dayton, OH USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Cincinnati, OH USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Columbus, OH USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Cleveland, OH USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Toledo, OH USA 10/12/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Dayton, OH USA 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Columbus, OH USA 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Cleveland, OH USA 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Cincinnati,, OH USA 05/30/2006
Details Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme Akron, OH USA 05/29/2006
Details A Novel Mechanism for Treating Cancer Employing Homeopathic and Bioenergetic Mechanisms of Action Dublin, OH USA 01/08/2006
Details Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme Cleveland, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Cleveland, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Akron, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Dayton, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Cincinnati, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Columbus, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Youngstown, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Cleveland, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Toledo, OH USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Toledo, OH USA 11/27/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Cleveland, OH USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Akron, OH USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Dayton, OH USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Cincinnati, OH USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Youngstown, OH USA 11/26/2005
Details Thalomid™ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma Dayton, OH USA 11/26/2005
Details Phase II Study of Multi-Agent Intrathecal and Systemic Chemotherapy With Radiotherapy in Children With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors Cleveland, OH USA 11/21/2005
Details FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia Cincinnati, OH USA 11/11/2005
Details Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors Cincinnati, OH USA 11/11/2005
Details Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Akron, OH USA 11/06/2005
Details A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy , OH USA 11/06/2005
Details A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy Akron, OH USA 11/06/2005



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Gliadel® Wafer | Temodar®
Fundraising For Research | Unsubscribe | Feedback | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE

Copyright (c) 1993 - 2008 by The Musella Foundation

Website Design By
World Wide Websites